Neuropathy in a rat model of mild diabetes induced by multiple low doses of streptozotocin: Effects of the antioxidant stobadine in comparison with a high-dose α-lipoic acid treatment

General Physiology and Biophysics

Volumn 29, Issue 1, 2010, Pages 50-58

  Skalská, Silvia ^a   Kučera, Pavol ^b   Goldenberg, Zoltán ^b   Štefek, Milan ^a   Kyselová, Zuzana ^a   Jariabka, Pavol ^a   Gajdošíková, Alena ^a   Klobučníková, Katarína ^b   Traubner, Pavel ^b   Štolc, Svorad ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

lipoic acid; Diabetes; Neuropathy; Oxidative stress; Stobadine

Indexed keywords

STOBADINE; STREPTOZOCIN; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE MODEL; DRUG MEGADOSE; HYPERGLYCEMIA; HYPOXEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOTOR NERVE CONDUCTION; NERVE STIMULATION; NONHUMAN; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; CARBOLINES; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; HUMANS; MALE; NEURAL CONDUCTION; RATS; RATS, WISTAR; STREPTOZOCIN; THIOCTIC ACID; TREATMENT OUTCOME;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77952084858     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2010_01_50     Document Type: Article

References (71)

1. Archibald V., Cotter M. A., Keegan A., Cameron N. E. (1996): Contraction and relaxation of aortas from diabetic rats: effects of chronic antioxidant and aminoguanidine treatments. Naunyn Schmiedebergs. Arch. Pharmacol. 353, 584-591; doi:10.1007/BF00169180
2. Baba M., Nukada H., McMorran D., Takahashi K., Wada R., Yagihashi S. (2006): Prolonged ischemic conduction failure after reperfusion in diabetic nerve. Muscle Nerve 33, 350-355; doi:10.1002/mus.20474
3. Baynes J. W. (1991): Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412; doi:10.2337/diabetes.40.4.405
4. Baynes J. W., Thorpe S. R. (2000): Glycoxidation and lipoxidation in atherogenesis. Free Radic. Biol. Med. 28, 1708-1716; doi: 10.1016/S0891-5849(00) 00228-8
5. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. (1990): Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87, 1620-1624; doi: 10.1073/pnas.87.4.1620
6. Bíró K., Jednákovits A., Kukorelli T., Hegedüs E., Korányi L. (1997): Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats. Brain Res. Bull. 44, 259-263; doi: 10.1016/S0361-9230(97)00118-4
7. Camera A., Hopps.E., Caimi G. (2007): Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects. Minerva Endocrinol. 32, 209-229
8. Cameron N. E., Cotter M. A., Robertson S. (1991): Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 40, 532-539; doi:10.2337/diabetes.40.5.532
9. Cameron N. E., Cotter M. A., Dines K., Love A. (1992): Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35, 946-950; doi:10.1007/BF00401423
10. Cameron N. E., Cotter M. A., Dines K. C., Maxfield E. K. (1993): Pharmacological manipulation of vascular endothelium in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 36, 516-522; doi:10.1007/ BF02743267
11. Cameron N. E., Cotter M. A. (1994): Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneural oxygen tension in streptozotocin-diabetic rats. Diabetologia 31, 220-225; doi: 10.1007/BF00571955
12. Cameron N. E., Cotter M. A., Archibald V., Dines K. C., Maxfield E. K. (1994): Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37, 449-459; doi:10.1007/ s001250050131 (Pubitemid 24133646)
13. Cameron N. E., Cotter M. A., Horrobin D. H., Tritschler H. J. (1998): Effect of a-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia 4, 390-399; doi: 10.1007/s001250050921
14. Cameron N. E., Cotter M. A. (1999): Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. 45, 137-146; doi:10.1016/S0168-8227(99)00043-51
15. Eaton R. P., Quails C., Bicknell J., Sibbitt W. L. Jr., King M. K., Griffey R. H. (1996): Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis. Diabetologia 39, 439-446; doi:10.1007/BF00400675 (Pubitemid 26093872)
16. Evans J. L., Goldfine I. D. (2000): Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type II diabetes. Review. Diabetes Technol. Ther. 2, 401-413.; doi:10.1089/15209150050194279
17. Fernyhough P., Huang T. J., Verkhratsky A. (2003): Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy. J. Peripher. Nerv. Syst. 8, 227-235; doi: 10.1111/j.10859489.2003.03028.x
18. Franko J., Pomfy M., Nováková B., Benes L. (1999): Stobadine protects against ischemia-reperfusion induced morphological alterations of cerebral microcirculation in dogs. Life Sci. 65, 1963-1967; doi:10.1016/S0024-3205(99)00456-7 (Pubitemid 29506937)
19. Ford I., Cotter M. A., Cameron N. E., Greaves M. (2001): The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism 50, 868-875; doi: 10.1053/meta.2001. 24914 (Pubitemid 32755001)
20. Gouty S., Regalia J., Cai F., Heike C. J. (2003): Alpha-lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats. Auton. Neurosci. 108, 32-44; doi:10.1016/j.autneu. 2003.08.004
21. Günes A., Ceylan A., Sarioglu Y., Štefek M., Bauer V., Karasu C. (2005): Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants. Fundam. Clin. Pharmacol. 19, 73-79; doi:10.1111/j. 14728206.2004.00312.x
22. Habib M.P., Dickerson F.D., Mooradian A.D. (1994): Effect of diabetes, insulin, and glucose load on lipid peroxidation in the rat. Metabolism 43, 1442-1445; doi: 10.1016/00260495(94)90042-90046
23. Horáková L'., Stolc S. (1998): Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Review. Gen. Pharmacol. 30, 627-638; doi:10.1016/S0306-3623(97)00300-5
24. Jacob S., Henriksen E. J., Schiemann A. L., Simon I., Claney D. E., Trischler H. J., Jung W. L., Augustin H. J., Dietze G. J. (1995): Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 45, 872-874
25. Januszewski A. S., Alderson N. L., Metz T. O., Thorpe S. R., Baynes J. W. (2003): Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochem. Soc. Trans. 31, 1413-1416; doi:10.1042/BST0311413
26. Kyselova Z., Gajdosik A., Gajdosikova A., Ulicna O., Mihalova D., Karasu C., Stefek M. (2005): Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT. MoL Vis. 11, 56-65 (Pubitemid 41358308)
27. Larsen M. O., Wilken M., Gotfredsen C. F., Carr R. D., Svendsen O., Rolin B. (2002): Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes. Am. J. Physiol. Endocrinol. Metab.282, E1342-1351
28. Lattimer S. A., Sima A. A., Greene D. A. (1989): In vitro correction of impaired Na+, K+-ATPase in diabetic nerve by protein kinase C agonists. Am. J. Physiol. 256, 264-269
29. Like A. A., Rossini A. A. (1976): Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415-417; doi: 10.1126/science. 180605
30. Low P. A., Ward K., Schmelzer J. D., Brimijoin S. (1985): Ischaemic conduction failure and energy metabolism in experimental diabetic neuropathy. Am. J. Physiol. 248, 457-462
31. Low P. A., Lagerlund T. D., McManis P. G. (1989): Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 31, 355-438; doi:10.1016/S0074-7742(08)60283-4
32. Low P. A., Nickander K. K., Tritschler H. J. ( 1997): The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46, 38-42
33. Low P. A., Schmelzer J. D., Zollman P. J., Tritschler H. J. (1996): α-Lipoic acid prevents the deficit in glucose uptake in experimental diabetic neuropathy. Diabetologia 39, A34
34. Metz T. O., Alderson N. L., Chachich M. E., Thorpe S. R., Baynes J. W. (2003): Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications. J. Biol. Chem. 278, 42012-42019; doi: 10.1074/jbc.M304292200
35. Nagamatsu M., Nickander K. K., Schmelzer J. D., Raya A., Wittrock D. A., Tritschler H., Low P. A. (1995): Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18, 1160-1167; doi: 10.2337/diacare. 18.8.1160
36. Nangle M. R., Gibson T. M., Cotter M. A., Cameron N. E. (2006): Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Planta Med. 72, 494-500; doi: 10.1055/S-2005-916262
37. Packer L., Witt E. H., Tritschler H. J. (1995): Alpha-lipoic acid as a biological antioxidant (Review). Free Rad. Biol. Med. 19, 227-250; doi: 10.1016/0891-5849(95)00017-R
38. Packer L., Tritschler H. J. (1996): Alpha-lipoic acid: the metabolic antioxidant. Free Rad. Biol. Med. 20, 625-626; doi:10.1016/0891-5849(95)02129-9
39. Packer L., Kraemer K., Rimbach G. (2001): Molecular aspects of lipoic acid in the prevention of diabetes complications. Review. Nutrition 17, 888-895; doi:10.1016/S08999007(01)00658-X (Pubitemid 33001657)
40. 2+-ATPaSe activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E. Biochim. Biophys. Acta 1588, 71-78
41. Pieper G. M., Langenstroer P., Gross G. J. ( 1993): Hydroxyl radicals mediate injury to endothelium-dependent relaxation in diabetic rats. MoL Cell. Biochem. 122, 139-145; doi:10.1007/BF01076098
42. Pop-Busui R., Sima A., Stevens M. (2006): Diabetic neuropathy and oxidative stress. Diabetes Metab. Res. Rev. 22, 257-273; doi:10.1002/dmrr.625
43. Ravingerova T., Neckar J., Kolar F., Stetka R., Volkovova K., Ziegelhöffer A., Styk J. (2001): Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia ? Basic Res. Cardiol. 96, 160-168; doi: 10.1007/s003950170066
44. Sango K., Horie H., Okamura A., Inoue S., Takenaka T. (1995): Diabetes impairs DRG neuronal attachment to extracellular matrix protein in vitro. Brain Res. Bull. 37, 533-537; doi:10.1016/0361-9230(95)00057-L
45. Schmelzer J. D., Zochodne D. W., Low P. A. (1989): Ischemic and reperfusion injury of rat peripheral nerve. Proc. Natl. Acad. Sci. U.S.A. 86, 1639-1642; doi:10.1073/pnas.86.5.1639
46. Sima A. A., Prashar A., Nathaniel V., Bril V., Werb M. R., Greene D. A. (1993): Overt diabetic neuropathy: repair of axoglial dysjuntion and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity. Diabet. Med. 10, 115-121; doi:10.1111/j. 1464-5491.1993.tb00027.x
47. Sima A. A., Sugimoto K. (1999): Experimental diabetic neuropathy: an update. Diabetologia 42, 773-788; doi:10.1007/s001250051227
48. Skalska S., Kyselova Z., Gajdosikova A., Karasu C., Stefek M., Stole S. (2008): Protective effect of stobadine on NCV in streptozotocin-induced diabetic rats: augmentation by vitamin E. Gen. Physiol. Biophys. 27, 106-114
49. Sotnikova R., Stefek M., Okruhlicova L., Navarova J., Bauer V., Gajdosik A., Gajdosiková A. (2001): Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairment in streptozotocin-diabetic rats. Methods Find. Exp. Clin. Pharmacol. 23, 121-129; doi:10.1358/mf.2001.23.3. 627943
50. Sotnikova R., Skalska S., Okruhlicova L., Navarova J., Kyselova Z., Zurova J., Stefek M., Hozova R., Nosalova V (2006): Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozoticin-induced diabetes. Gen. Physiol. Biophys. 25, 289-302
51. Stefek M., Drozdikova I., Vajdova K (1996): The pyridoindole antioxidant stobadine inhibited glycation-induced absorbance and fluorescence changes in albumin. Acta Diabetol. 33, 35-40; doi:10.1007/BF00571938 (Pubitemid 26096154)
52. Stefek M., Sotnikova R., Okruhlicova L., Volkovova K., Kucharska J., Gajdosik A., Gajdosikova A., Mihalova D., Hozova R., Tribulova N., Gvozdjakova A (2000): Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium. Acta Diabetol. 37, 111-117; doi: 10.1007/s005920070012 (Pubitemid 32157310)
53. Stefek M., Gajdosik A., Tribulova N., Navarova J., Volkovova K., Weismann P., Gajdosikova A., Drimal J., Mihalova D (2002a): The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen crosslinking in streptozotocin-induced diabetic rats. Methods Find. Exp. Clin. Pharmacol. 24, 565-571
54. Stefek M., Tribulova N., Gajdosik A., Gajdosikova A. (2002b): The pyridoindole antioxidant stobadine attenuates histochemical changes in kidney of streptozotocin-induced diabetic rats. Acta Histochem. 104, 413-417; doi: 10.1078/00651281-00681 (Pubitemid 36041809)
55. Strupp M., Jund R., Schneider U., Grafe P. (1991): Glucose availability and sensitivity to anoxia of isolated rat peroneal nerve. Am. J. Physiol. 261, E389-394
56. Tankova T., Koev D., Dakovska L. (2004): Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study). Rom. J. Intern. Med. 42, 457-464
57. Taylor P. D., Poston L. (1994): The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br. J. Pharmacol. 113, 801-808
58. Ulusu N. N., Sahilli M., Avci A., Canbolat O., Ozansoy G., Ari N., Bali M., Stefek M., Stolc S., Gajdosik A., Karasu C. (2003): Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Neurochem. Res. 28, 815-823; doi: 10.1023/A:1023202805255
59. Van Dam P. S., Van Asbeck B. S., Erkelens D. W., Marx J. J., Gisppen W H., Bravenboer B. (1995): The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab. Rev. 1, 181-192; doi:10.1002/dmr. 5610110303
60. Van Dam P. S., Van Asbeck B. S., Van Oirschot J. F., Biessels G. J., Hamers F. P, Marx J. J. (2001): Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state. Eur. J. Clin. Invest. 31, 417-424; doi:10.1046/j.1365-2362.2001.00832.x
61. Varkonyi T., Kempler P. (2008): Diabetic neuropathy: new strategies for treatment. Diabetes Obes. Metab. 10, 99-108
62. Vlkovicová J., Javorková V., Stefek M., Kysel'ová Z., Gajdosíková A., Vrbjar N. (2006): Effect of the pyridoindole antioxidant stobadine on the cardiac Na(+),K(+)-ATPase in rats with streptozotocin-induced diabetes. Gen. Physiol. Biophys. 25, 111-124
63. Vrbjar N., Strelková S., Javorková V., Vlkovicová J., Mézesová L., Stefek M., Kysel'ová Z., Gajdosíková A. (2007): Effect of the pyridoindole antioxidant stobadine on ATP-utilisation by renal Na,K-ATPase in rats with streptozotocin-induced diabetes. Gen. Physiol. Biophys. 26, 207-213
64. Wang Y., Schmelzer J. D., Schmeichel A., Iida H., Low P. A. (2004): Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy. J. Neurol. Sci. 227, 101-107; doi:10.1016/j.jns.2004.09.020
65. Williamson J. R., Chang K., Frangos M., Hasan K.S., Ido Y., Kawamura T., Nyengaard J. R., van den Enden M., Kilo C., Tilton R. G. (1993): Hyperglycaemic pseudohypoxia and diabetic complications (Review). Diabetes 42, 801-813; doi: 10.2337/diabetes.42.6.801 (Pubitemid 23151571)
66. Yülek F., Or M., Ozoǵul C., Isik A. C., Ari N., Śtefek M., Bauer V., Karasu C. (2007): Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress. Arch. Med. Res. 38, 503-511; doi:10.1016/j.arcmed.2007.02.006
67. Ziegelhöffer A., Styk J., Ravingerová T., Seboková J., Volkovová K., Waczulíková I., Cársky J., Dzurba A., Docolomanský P. (1999): Prevention of processes coupled with free radical formation prevents also the development of calcium-resistance in the diabetic heart. Life Sci. 65, 1999-2001; doi:10.1016/S0024-3205(99)00464-6
68. Ziegler D., Gries F. A. (1997): Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 46, S62-66 (Pubitemid 27377401)
69. Ziegler D., Reljnovic M., Mehnert H., Gries F. A. (1999): Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: Current evidence from clinical trials. Exp. Clin. Endocrinol. Diabetes 107, 421-430; doi:10.1055/s-0029-1212132
70. Ziegler D. (2004): Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat. Endocrinol. 3, 173-189; doi: 10.2165/00024677-200403030-00005
71. Ziegler D. (2008): Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 31, S255-261; doi:10.2337/dc08-s263